ACKNOWLEDGEMENT AND AGREEMENTAcknowledgement and Agreement • May 12th, 2020 • OncoCyte Corp • In vitro & in vivo diagnostic substances
Contract Type FiledMay 12th, 2020 Company IndustryThis ACKNOWLEDGEMENT AND AGREEMENT (the “Agreement”) is effective as of May 7, 2020, by and between, Oncocyte Corporation (the “Company”) and Lyndal Hesterberg, an individual (“Participant”), with reference to the following facts:
ACKNOWLEDGEMENT AND AGREEMENTAcknowledgement and Agreement • May 12th, 2020 • OncoCyte Corp • In vitro & in vivo diagnostic substances
Contract Type FiledMay 12th, 2020 Company IndustryThis ACKNOWLEDGEMENT AND AGREEMENT (the “Agreement”) is effective as of May 7, 2020, by and between, Oncocyte Corporation (the “Company”) and Mitch Levine, an individual (“Participant”), with reference to the following facts: